Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues

Journal of Peptide Research

Volumn 60, Issue 2, 2002, Pages 128-140

  Schumann, C ^a   Seyfarth, L ^a   Greiner, G ^a   Paegelow, I ^a   Reissmann, Siegmund ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Agonists; Antagonists; Backbone cyclization; Bradykinin; Dipeptide building units; Potentiation; Side chain cyclization; SPPS

Indexed keywords

BRADYKININ; CYCLOPEPTIDE; DIPEPTIDE; DRUG DERIVATIVE; LACTAM; BRADYKININ ANTAGONIST; BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR AGONIST; GLUTAMIC ACID; LYSINE; PHENYLALANINE DERIVATIVE;

ACYLATION; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; CYCLIZATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ILEUM; MASS SPECTROMETRY; MUSCLE CONTRACTION; PHYSIOLOGY; PROTEIN CONFORMATION; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS; UTERUS; WISTAR RAT; ANIMAL EXPERIMENT; ANIMAL TISSUE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; STRUCTURE ANALYSIS;

ACYLATION; AMINO ACID SEQUENCE; ANIMALS; BRADYKININ; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIZATION; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; ILEUM; LACTAMS; MUSCLE CONTRACTION; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; UTERUS; ANIMAL; SUPPORT, NON-U.S. GOV'T;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0035991354     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2002.02986.x     Document Type: Article

References (75)

1. Bradykinin antagonists: Development and applications
2. Pharmacology of bradykinin and related kinins
3. Biochemical and molecular pharmacology of kinin receptors
4. Classification of kinin receptors
5. 2 bradykinin receptor
6. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor
7. 1 receptors: A review
8. 1 bradykinin receptor
9. 1 receptor gene
10. De novo formation of vascular receptors for bradykinin
11. Metabolism-resistant bradykinin antagonists: Development and applications
12. Structural modifications of highly potent bradykinin antagonists and their pharmacological consequences
13. Bradykinin-related compounds having anti-cancer activity in vivo superior to cisplatin and SU5416
14. Development of new analogs of the highly potent anticancer compound BKM-570
15. Competitive antagonist of bradykinin
16. Probing the bradykinin receptor: Mapping the geometric topography using ethers of hydroxyproline in novel peptides
17. New, long-acting, potent bradykinin antagonist
18. A new class of bradykinin antagonists containing indanylglycine
19. Novel highly potent bradykinin antagonists containing penta-fluoro-phenylalanine
20. New analogues of bradykinin containing a conformationally restricted dipeptide fragment in their molecules
21. 2 kinin receptor
22. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety
23. 2 kinin receptor
24. 2 kinin receptor
25. 2-receptor antagonists
26. 2 receptor
27. 2-receptor antagonists. 1. Construction of the basic framework
28. 2 receptor antagonist. FR 167344, on different in vivo animal models of inflammation
29. 2 receptor
30. 2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia
31. 2 receptor antagonist
32. Combined approach of NMR and molecular dynamics within a biphasic membrane mimetic. Conformation and orientation of the bradykinin antagonist Hoe 140
33. NMR and computational evidence that high affinity bradykinin receptor antagonist adopt C-terminal β-turns
34. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions
35. 1-specific receptor antagonists B-9430, B-9436, and B-9858
36. Conformational analysis of the highly potent bradykinin antagonist Hoe 140 by means of two different computational methods
37. Circular dichroism of bradykinin and related peptides
38. Molecular architecture of peptide hormones. Optical rotatory dispersion of cholecystokinin-pancreozymin, bradykinin and 6-glycine bradykinin
39. The solution conformation of bradykinin
40. A CD and a NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions
41. Chimeric amino acids in cyclic bradykinin analogs: Evidence for receptor-bound turn conformation
42. Evidence for receptor-bound turn conformations of bradykinin and angiotensin II
43. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues
44. NMR and molecular modeling investigations of the neuropeptide bradykinin in three different solvent systems: DMSO, 9:1 dioxane/water, and in the presence of 7-4 mM lyso phosphatidyl choline micelles
45. Three-dimensional structure of bradykinin in SDS micelles. Study using nuclear magnetic resonance, distance geometry, and restrained molecular mechanics and dynamics
46. 8]bradykinin
47. Proton magnetic resonance studies of bradykinin antagonists
48. 2 receptor: Receptor binding and solution backbone conformation
49. Design and synthesis of linear and cyclic bradykinin antagonists
50. Cyclic analogue of bradykinin possesing selective and prolonged biological activity
51. Cyclic analogues of bradykinin. IV. Structure-function relationships in the series of bradykinin cycloanalogues
52. Design of potent, cyclic, peptide bradykinin receptor antagonists from conformationally constrained linear peptides
53. 2 antagonist design
54. Synthesis and biological activity of some linear and cyclic kinin analogues
55. Cyclic analogues of wasp kinins from Vespa analis and Vespa tropica
56. Conformation of cyclobradykinin by NMR and distance geometry calculations
57. Synthesis and biological activities of head to tail cyclic bradykinin analogues of varying ring size
58. 6-bradykinin analogues containing N-benzylglycine in place of phenylalanine
59. New cyclic bradykinin antagonists containing disulfide and lactam bridges at the N-terminal sequence
60. Design, synthesis and characterization of bradykinin antagonists via cyclization of the modified backbone
61. Structure-activity relationships of kinins
62. Chemistry and biological activity of peptides related to bradykinin
63. Backbone cyclization: A new method for conferring conformational constraint on peptides
64. Synthesis of N-carboxyalkyl and N-aminoalkyl functionalized dipeptide building units for the assembly of backbone cyclic peptides
65. Synthesis of different types of dipeptide building units containing N- or C-terminal arginine for the assembly of backbone cyclic peptides
66. Comparative study of methods to couple hindered peptides
67. A new general solid-phase method for the synthesis of backbone-to-backbone cyclized peptides
68. Synthesis of differentially protected N-acylated reduced pseudopeptides as building units for backbone cyclic peptides
69. 2 receptor selective agonist which is not broken down by either kininase I or kininase II
70. Combination of allyl protection and HYCRAM™-linker technology for the syntheses of peptides with problematical amino acids and sequences
71. 2 receptor?
72. Kinins, receptors, kininases and inhibitors-Where did they lead us?
73. Cumulative dose-response curves. Technique for making of dose-response curves in isolated organs and the evaluation of drug parameters